134 related articles for article (PubMed ID: 3135919)
1. Central muscarinic cholinergic antagonists block wet-dog shakes produced by the TRH analog MK-771 in the rat.
Sills MA; Mellow AM; Sunderland T; Jacobowitz DM
Brain Res; 1988 Jun; 453(1-2):385-8. PubMed ID: 3135919
[TBL] [Abstract][Full Text] [Related]
2. Chronic administration of desipramine or nialamide decreases wet-dog shakes in rats produced by the TRH-analog MK-771.
Sills MA; Jacobowitz DM
Brain Res; 1987 Jan; 401(1):195-9. PubMed ID: 3101979
[TBL] [Abstract][Full Text] [Related]
3. Treatment of rats with the TRH analog MK-771. Down-regulation of TRH receptors and behavioral tolerance.
Simasko SM; Horita A
Neuropharmacology; 1985 Feb; 24(2):157-65. PubMed ID: 2986033
[TBL] [Abstract][Full Text] [Related]
4. Failure of muscarinic blockade to antagonize analepsis induced by thyrotropin-releasing hormone and MK-771 in the rat.
Santori EM; Schmidt DE; Kalivas PW; Horita A
Psychopharmacology (Berl); 1981; 74(1):13-6. PubMed ID: 6115440
[TBL] [Abstract][Full Text] [Related]
5. Induction of wet-dog shakes by intracerebral 'acid' TRH in rats.
Boschi G; Launay N; Rips R
Neurosci Lett; 1980 Feb; 16(2):209-12. PubMed ID: 6820479
[TBL] [Abstract][Full Text] [Related]
6. Effects of behaviorally active doses of thyrotropin-releasing hormone and its analog MK-771 on dopaminergic neuronal systems in the brain of the rat.
Yamada K; Demarest KT; Moore KE
Neuropharmacology; 1984 Jul; 23(7A):735-9. PubMed ID: 6433220
[TBL] [Abstract][Full Text] [Related]
7. Inhibition via muscarinic M-1 receptor stimulation of TRH-induced prolactin release in estrogen-primed rats.
Kumagai M; Yamada K; Matsuo N; Furukawa T
Arch Int Pharmacodyn Ther; 1988; 293():236-44. PubMed ID: 2901825
[TBL] [Abstract][Full Text] [Related]
8. Lack of interaction between thyrotropin releasing hormone and its analogs with 3H-quinuclidinyl benzilate recognition sites in the rat striatum.
Das S; Bhargava HN
Neuropharmacology; 1985 Jul; 24(7):681-3. PubMed ID: 3927185
[TBL] [Abstract][Full Text] [Related]
9. Propranolol and methylatropine antagonize the cardiovascular effects produced by microinjection of the TRH analog MK-771 into the preoptic suprachiasmatic nucleus.
Sills MA; Jacobowitz DM
Peptides; 1988; 9(4):893-8. PubMed ID: 3147455
[TBL] [Abstract][Full Text] [Related]
10. Involvement of catecholaminergic neurones and alpha-adrenoceptors in the wet-dog shake and forepaw licking behaviour produced by the intrathecal injection of an analogue of thyrotrophin-releasing hormone (CG 3509).
Fone KC; Bennett GW; Marsden CA
Neuropharmacology; 1987 Aug; 26(8):1147-55. PubMed ID: 2889164
[TBL] [Abstract][Full Text] [Related]
11. Role of central dopaminergic and 5-hydroxytryptaminergic projections in the behavioral responses elicited by thyrotropin-releasing hormone in rats.
Funk D; Post RM; Pert A
Psychopharmacology (Berl); 1997 Oct; 133(4):356-62. PubMed ID: 9372535
[TBL] [Abstract][Full Text] [Related]
12. Reversal of hemorrhagic shock in rats using the metabolically stable thyrotropin-releasing hormone analog taltirelin hydrate.
Asai H; Watanabe Y; Yamauchi-Kohno R; Doi O
J Recept Signal Transduct Res; 2011 Dec; 31(6):416-22. PubMed ID: 22044177
[TBL] [Abstract][Full Text] [Related]
13. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
Fone KC; Johnson JV; Bennett GW; Marsden CA
Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
[TBL] [Abstract][Full Text] [Related]
14. Grooming behavior induced by ACTH involves cerebral cholinergic neurons and muscarinic receptors.
Dunn AJ; Vigle G
Neuropharmacology; 1985 Apr; 24(4):329-31. PubMed ID: 2987726
[TBL] [Abstract][Full Text] [Related]
15. Chronic thyrotropin releasing hormone (TRH) administration on TRH receptors and muscarinic cholinergic receptors in CNS.
Ogawa N; Mizuno S; Nukina I; Tsukamoto S; Mori A
Brain Res; 1983 Mar; 263(2):348-50. PubMed ID: 6301651
[TBL] [Abstract][Full Text] [Related]
16. Studies on the mechanism of wet dog shakes produced by carbachol in rats.
Turski WA; Czuczwar SJ; Turski L; Sieklucka-Dziuba M; Kleinrok Z
Pharmacology; 1984; 28(2):112-20. PubMed ID: 6200891
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals.
Helke CJ; Phillips ET
J Pharmacol Exp Ther; 1988 Apr; 245(1):41-6. PubMed ID: 2834544
[TBL] [Abstract][Full Text] [Related]
18. Central thyrotropin-releasing hormone increases hepatic cyclic AMP through vagal-cholinergic and prostaglandin-dependent pathways in rats.
Yoneda M; Kono T; Watanobe H; Tamano M; Shimada T; Hiraishi H; Nakamura K
Peptides; 2005 Sep; 26(9):1573-9. PubMed ID: 16112395
[TBL] [Abstract][Full Text] [Related]
19. Thyrotropin-releasing hormone and its analog MK-771 increase the cerebroventricular perfusate content of dihydroxyphenylacetic acid.
Nielsen JA; Moore KE
J Neurochem; 1984 Aug; 43(2):593-6. PubMed ID: 6429282
[TBL] [Abstract][Full Text] [Related]
20. Brainstem thyrotropin-releasing hormone regulates food intake through vagal-dependent cholinergic stimulation of ghrelin secretion.
Ao Y; Go VL; Toy N; Li T; Wang Y; Song MK; Reeve JR; Liu Y; Yang H
Endocrinology; 2006 Dec; 147(12):6004-10. PubMed ID: 16959836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
